ADAM12 expression predicts clinical outcome in estrogen receptor-positive breast cancer.
International journal of clinical and experimental pathology（2015）
Abstract
ADAM12 appears to be a prognostic marker in ER-positive breast cancer.
MoreTranslated text
Key words
ADAM12,breast cancer,clinical outcome,estrogen receptor
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined